[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ipharmacenter](/creator/twitter/ipharmacenter)
"#NovoNordisk Acquires #AkeroTherapeutics for $XXX Billion Expanding Its #MASH Portfolio with First-in-Class FGF21 Analogue #pharma #breaking #breakingnews #news #media #pharmaceutical #healthcare"  
[X Link](https://x.com/ipharmacenter/status/1978679911624655322) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-16T04:30Z XXX followers, XX engagements


"Eli Lilly's orforglipron shines in Phase X trials for Type X Diabetes Great potential for a new oral treatment option. Read more about these promising results: #pharma #pharmaceutical #breakingnews #weightloss #revenues #Type2Diabetes #EliLilly"  
[X Link](https://x.com/ipharmacenter/status/1978705210009965010) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-16T06:10Z XXX followers, XX engagements


"#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:"  
[X Link](https://x.com/ipharmacenter/status/1979773804160364847) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-19T04:57Z XXX followers, XXX engagements


"#ESMO2025 is dominated by latest updates from #Merck #AstraZeneca #Pfizer and #JohnsonandJohnson #ESMO25 #ESMO2025 #ESMOwithiPharmaCenter #CancerResearch #Oncologist #OncoAlert #OncoAlertTopTweet #ESMOAmbassadors #immunotherapy #JohnsonandJohnson"  
[X Link](https://x.com/ipharmacenter/status/1980152261319004560) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-20T06:01Z XXX followers, XXX engagements


"#Novartis #Pluvicto Shows Significant Delay in Disease Progression in Metastatic #ProstateCancer #ESMO25 #ESMO2025 #ESMOAmbassadors #OncoAlert #OncoAltertTopTweet #Cancer #CancerResearch #Berlin"  
[X Link](https://x.com/ipharmacenter/status/1980509486222831736) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T05:40Z XXX followers, XX engagements


"#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas"  
[X Link](https://x.com/ipharmacenter/status/1980534244800856314) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:18Z XXX followers, XX engagements


"#Pfizers #Braftovi and #Mektovi Combination Shows Impressive Four-Year Survival in Advanced #LungCancer Patients #ESMO25 #ESMO2025 #ESMOUpdates #news #media #breaking #pharma #pharmaceutical #ESMOAmbassadors"  
[X Link](https://x.com/ipharmacenter/status/1980537653461467368) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:32Z XXX followers, XX engagements


"Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS"  
[X Link](https://x.com/ipharmacenter/status/1980540251014857177) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:42Z XXX followers, XXX engagements


"Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025"  
[X Link](https://x.com/ipharmacenter/status/1980674362329252263) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:35Z XXX followers, XX engagements


"#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert"  
[X Link](https://x.com/ipharmacenter/status/1980675281460556163) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:39Z XXX followers, XX engagements


"#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare"  
[X Link](https://x.com/ipharmacenter/status/1980695566947373389) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T17:59Z XXX followers, XX engagements


"AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical"  
[X Link](https://x.com/ipharmacenter/status/1980696260467388675) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T18:02Z XXX followers, XXX engagements